These studies revealed nine cancer genes (TP53, ESR1, GATA3, KMT2C, NCOR1, AKT1, NF1, RIC8A and RB1) to be highly mutated in the metastatic disease when compared with early breast cancer (114). This evidence concerns the gene ESR1 and metastatic neoplasm.